ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,466,892, issued on Nov. 11, was assigned to The Regents of the University of California (Oakland, Calif.), THE TRUSTEES OF PRINCETON UNIVERSITY (Princeton, N.J.) and THE SIMONS FOUNDATION INC. (New York).

"Systems and methods for targeting cancer cells" was invented by Wendell A. Lim (San Francisco), Olga G. Troyanskaya (Princeton, N.J.), Benjamin Vandersluis (New York) and Ruth Dannenfelser (Princeton, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides immune cells genetically modified to produce two antigentriggered polypeptides, each recognizing a different cell surface antigen, wherein the two different cell surface ...